331 filings
Page 2 of 17
8-K
awd67
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
kvqw8q5meaf7
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:24pm
8-K
pkueqrrwlwyy l43p5qr
6 Jun 23
Other Events
5:39pm
8-K
u08ckd f4yf
4 Apr 23
Other Events
12:32pm
8-K
ge4b5avb
31 Jan 23
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
1:36pm
8-K
c6lyewngs si
25 Jan 23
Other Events
2:07pm
424B3
g701w
15 Dec 22
Prospectus supplement
5:12pm
EFFECT
7f83w5xqnee ndr
13 Dec 22
Notice of effectiveness
12:15am
CORRESP
srrkrc65mi
8 Dec 22
Correspondence with SEC
12:00am
UPLOAD
953oh8 wqjcztv
7 Dec 22
Letter from SEC
12:00am
8-K
f7myq 3kgrc
17 Oct 22
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
9:13am
8-K
hdtt 1li0jucaif53
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
4ivfdab05r6 jrut
21 Sep 22
Other Events
3:49pm
8-K
9kyw2l2eg
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am